1. Introduction {#s0005}
===============

Intracellular metabolic reactions provide a cell with basic biochemical building blocks, energy, and a thermodynamically favorable environment to sustain its life. Because of the large connectivity inherent to metabolic networks via metabolites participating in multiple metabolic reactions, determination of system-level changes in intracellular metabolic fluxes of organisms is important for understanding the fundamental mechanisms of their metabolic responses to environmental or genetic perturbations [@bb0005; @bb0010].

^13^C metabolic flux analysis (^13^C-MFA) allows intracellular fluxes to be quantified experimentally. In this approach, cells are grown on ^13^C-labeled substrates until the cells are at both metabolic steady state (i.e. when concentrations of metabolites remain stable over time) and isotopic steady state (i.e. when the isotope label is distributed throughout the network, and all isotopomer fractions are constant over time). Then the level of ^13^C enrichment in metabolites of the cells is measured by mass spectrometry (MS) or nuclear magnetic resonance (NMR). Intracellular flux distribution is reconstituted from the ^13^C enrichment patterns [@bb0015; @bb0020; @bb0025; @bb0030; @bb0035; @bb0040]. System-wide quantification of intracellular metabolic fluxes using ^13^C-MFA, however, is challenging not only because of the extensive instrumentation required but also because of the limited number of fluxes and conditions that can be experimentally measured. Typically, ^13^C-MFA focuses on central carbon metabolism [@bb0035; @bb0040; @bb0045; @bb0050].

An alternative method that is widely used for system-level studies of metabolism is a computational modeling approach called flux balance analysis (FBA). FBA predicts metabolic flux distributions at steady state by making use of in silico genome-scale metabolic models [@bb0055]. These genome-scale metabolic models are assembled and manually-curated from annotated genome, biochemical, genetic, and cell phenotype data [@bb0055; @bb0060; @bb0065]. To use FBA, a genome-scale metabolic model is converted into a *m* × *n* stoichiometric matrix, *S*, where the rows in *S* correspond to the *m* metabolites of the metabolic network, and the columns represent the *n* reactions ([Fig. 1](#f0005){ref-type="fig"}a). Each matrix element *s~ij~*, indicates a stoichiometric coefficient, that is, the number of molecules of the *i*th metabolite participating in the *j*th reaction. *s~ij~* = 0 means that the *i*th metabolite is not involved, and a positive or a negative *s~ij~* indicates that the *i*th metabolite is a product or a reactant of the *j*th reaction, respectively. Under the steady state assumption, the metabolic flux distribution can be represented mathematically by *S*·*v* = 0, where *v* is a column vector whose elements are the unknown reaction rates (fluxes) through each of the reactions of *S* ([Fig. 1](#f0005){ref-type="fig"}b). Since genome-scale metabolic models include all possible metabolic reactions implied by the genome annotation regardless of whether the annotated metabolic genes are expressed in a given environment, the resulting system *S*·*v* = 0, is in general underdetermined [@bb0070; @bb0075]. Thus, physiologically meaningful flux solutions need to be narrowed down from all the possible flux distributions by imposing additional constraints on the system and by optimizing certain objective functions when performing FBA ([Fig. 1](#f0005){ref-type="fig"}c) [@bb0080]. The standard FBA involves solving the following linear optimization problem:$$\begin{array}{l}
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\end{array}$$where *v* is a flux vector representing the reaction rates of the *n* reactions in the network, *f* is a coefficient vector defining the organism\'s objective function, *S* is the stoichiometric matrix, and *lb* and *ub* are the minimum and maximum reaction rates through each reaction in *v*.

If the complete regulatory structure of an organism were known, it would be possible to produce context-specific constraints by computing which cellular components may be expressed in a given condition. However, the regulatory structure is unknown even for the relatively simple and extensively-studied bacterium, *Escherichia coli*, partly due to the lack of comprehensive transcription unit information and because of the lack of information on the relationship between genotype and phenotype [@bb0085].

Recent advances in omics technologies have enabled quantitative monitoring of the abundance of biological molecules at various levels in a high-throughput manner [@bb0090]. In the absence of complete information on regulatory rules, omics data can be integrated with genome-scale metabolic models to improve their predictive power [@bb0095; @bb0100]. For this purpose, transcriptomic data, i.e. genome-wide mRNA expression profiling data, is useful in some points compared to other omics platforms. Fluxomics (i.e. ^13^C-MFA) is the most direct measurement of metabolic phenotype, but has the disadvantages in that it is difficult to make measurements and only a limited number of fluxes can be determined as mentioned above. Metabolomics can also be useful, but typically fluxes are more informative than metabolite concentrations themselves, and it is challenging to determine fluxes from metabolite concentrations partly because each metabolite participates in multiple metabolic reactions. Similar to fluxes, specific classes of metabolites such as lipids or labile chemicals easily metabolized are still demanding to measure [@bb0105; @bb0110]. Unlike the first two omics data that cover a small share of all reactions in a genome-scale model, transcriptomics and proteomics are the platforms where a quantitative snapshot of molecular species at system-level is currently possible [@bb0115]. However, proteomics is a relatively immature technology compared to transcriptomics. The accuracy with which protein concentrations can be determined is much lower than that with which mRNA concentrations can be determined. On the other hand, RNA amount changes can be precisely measured in a highly automated process at low cost in comparison with the amount of data gathered [@bb0120; @bb0125]. By integrating transcriptomics data with genome-scale metabolic models, we can potentially determine metabolic fluxes through a relatively simple and low-cost omics technology. If other omics technology especially proteomics technology becomes as mature (e.g. wide coverage at lower cost with less effort) as that of transcriptomics, most of the methods introduced in this paper could be applied to other omics data, too.

Not only do genome-scale models benefit from transcriptomic data in creating condition- and tissue-specific models, but transcriptomic data itself can also benefit by being integrated onto the models. Although a large amount of transcriptomic data is continuously being generated, gaining meaningful insight into the functioning of cellular processes from mRNA levels is challenging because of the functional layers in between the two, such as translation, post-translational modifications, mRNA/protein degradation, and enzyme activity regulation by effectors (inhibitors or activators) [@bb0070; @bb0115; @bb0130]. Genome-scale metabolic models are well-suited to inferring metabolic phenotype from genotype using transcriptomic data, since the models are comprehensive repositories of biochemical data for organisms that enable the description of gene--protein--reaction relationships [@bb0065; @bb0095]. Whereas correlations between mRNA and fluxes have been often found to be poor, approaches taking into account for the large connectivity of metabolites inherent to metabolic networks have been successful in linking gene expression level to metabolites [@bb0010; @bb0135; @bb0140; @bb0145]. This implies that the consideration of the metabolic network is essential to draw a predictive relation from transcript abundances to fluxes [@bb0115].

For these reasons, there have been previous studies to integrate transcriptomic data with genome-scale metabolic models, and some of these methods have been covered in recent reviews [@bb0060; @bb0070; @bb0090; @bb0150; @bb0155; @bb0160; @bb0165]. However, most of these reviews broadly introduce methods inferring metabolic fluxes from various kinds of omics data and are not focused specifically on transcriptomic data. In addition, some of the reviews do not include the most recent methods since transcriptomic data-driven metabolic modeling methods are being developed at a fast pace [@bb0165]. In this mini-review, we focus on introducing methods for integrating transcriptomic data in genome-scale metabolic models, and we give a brief description of each one published to date. We exclude methods that require multi-omics datasets as input for an analysis even if they use transcriptomic data, because multi-omics studies are not common [@bb0170; @bb0175; @bb0180; @bb0185]. We categorize all methods that are covered in this paper based on four different grouping criteria, and we evaluate which group of methods is more suitable from a practical perspective. Lastly, we discuss several limitations of existing methods that new methods need to overcome.

2. Grouping criterion 1: requirement for multiple gene expression datasets as input {#s0010}
===================================================================================

As the first criterion, methods for estimating metabolic flux from transcriptomic data can be grouped by how many gene expression datasets are required as input. There are two representative methods that need multiple transcriptomic datasets measured under two or more conditions for an analysis.

First, Probabilistic Regulation Of Metabolism (PROM) published in 2010 is a method that integrates regulatory and metabolic networks [@bb0190]. It calculates the probability of a metabolic target gene being expressed relative to the activity of its regulating transcription factor from a large dataset of gene expression data, and the flux maxima of the metabolic reaction associated with the metabolic target gene is constrained by a factor of this probability ([Fig. 2](#f0010){ref-type="fig"}a). It has several advantages such as its ability to account for the presence of noise in the data, and to differentiate between a strong transcriptional regulator and a weak one. However, this method requires a large number of experimental datasets to calculate the probability of regulatory interactions between transcription factors and their target genes. It also requires a priori knowledge on transcription factor--target gene pairs. In the original paper, around 1300 microarrays and 2000 transcription factor--target interactions were used for *E. coli* and *Mycobacterium tuberculosis*.

Second, Metabolic Adjustment by Differential Expression (MADE) published in 2011, was developed to overcome the issue of selecting a subjective user-supplied threshold in defining a gene\'s high and low expression states [@bb0195]. MADE creates a sequence of binary expression states using several datasets for differential gene expression so as to find the model that most closely reproduces the observed expression changes ([Fig. 2](#f0010){ref-type="fig"}b). The principle of this method is that if the activity of a gene drastically changes from one condition to the other, the flux through the reaction controlled by that gene will change accordingly [@bb0200]. Using this method, the authors examined the metabolic effects of the transition from glucose- to glycerol-based growth in *Saccharomyces cerevisiae* over the course of time. They showed that the binary expression state changes calculated by MADE matched 98.7% of the feasible observed gene expression transitions (83.5% of all expression transitions). They also showed that, accompanied by these expression state changes, the flux variability of the model was increased after the shift to glycerol.

The other methods described below use a single gene expression dataset for each experimental condition. One of the possible concerns of using a single transcriptomic dataset may be the lack of proportionality between transcript and flux levels. Accounting for relative gene expression changes from multiple datasets as an indicator of the flux reconfiguration might seem to provide a more meaningful description. However, a recent research paper shows that the methods that use relative expression levels does not necessarily give more accurate flux predictions [@bb0165]. Although both methods have advantages, the requirement for multiple sets of input data such as transcription regulatory information or different gene expression datasets to perform the analysis is more onerous from a practical point of view.

3. Grouping criterion 2: requirement for a threshold to define a gene\'s high/low expression {#s0015}
============================================================================================

As the second criterion, methods can be grouped by whether they use a user-supplied threshold. Some methods require discretization (e.g. − 1, 0, 1), binarization (e.g. 1, 0), or classification (e.g. below/above threshold) of gene expression measurement data according to user-defined arbitrary thresholds to distinguish active and inactive states of the corresponding reactions. In addition to PROM, which is mentioned in the previous section, the following three methods also require thresholds.

An approach suggested by Åkesson et al. in 2004 is one of the earliest methods to integrate genome-wide expression data into genome-scale metabolic models [@bb0205]. In this method, the fluxes of reactions whose corresponding genes are not expressed are constrained as zero ([Fig. 2](#f0010){ref-type="fig"}c). A probe set for a gene is considered absent if it is undetected in all three replicates from independent cultures of the same condition. Using this principle, they combined microarray measurements of gene expression from chemostat and batch cultivations of *S. cerevisiae* with a genome-scale model for yeast, *i*FF708 [@bb0210]. The computed metabolic flux distributions were compared to experimental values from ^13^C-labeling experiments. The integration of expression data resulted in improved predictions of metabolic behavior in batch culture. Due to the Boolean nature of this method, failure in correctly detecting presence of lowly expressed genes may give rise to erroneous predictions.

Gene Inactivity Moderated by Metabolism and Expression (GIMME) introduced in 2008, creates a context-specific metabolic model that predicts the subset of reactions a cell is likely to use under particular conditions using gene expression data [@bb0215]. This method consists of a two-step procedure ([Fig. 2](#f0010){ref-type="fig"}d). First, the method finds a flux distribution that optimizes a given biological objective such as growth and/or ATP production using FBA. Then, the method minimizes the utilization of 'inactive' reactions whose corresponding mRNA transcript levels are below a given threshold. By avoiding the use of below-threshold reactions that are inconsistent with the flux distribution of the first step, the method was used to find context-specific metabolic flux distributions that best fit physiological data in *E.coli* and human skeletal muscle cells.

The integrative Metabolic Analysis Tool (iMAT) implements a method proposed by Shlomi et al. in 2008, which was developed for tissue-specific modeling of metabolism in mammalian cells [@bb0220; @bb0225]. In this method, gene expression data is discretized into tri-valued expression states, representing either low, moderate or high expression in the condition studied according to a user-specified threshold ([Fig. 2](#f0010){ref-type="fig"}e). Then, iMAT finds an optimal metabolic flux distribution that is the most consistent with the discrete gene expression data by maximizing the number of flux-carrying reactions associated with highly expressed enzymes and minimizing the number of flux-carrying reactions that correspond to lowly-expressed enzymes. This method does not require information on biomass composition or metabolite exchange. By integrating transcriptomic data with a global human metabolic model using this method, they predicted tissue-specific metabolic activity in ten different tissues. A method called EXAMO (EXploration of Alternative Metabolic Optima) is an extended version of iMAT that builds a context-specific model [@bb0230].

Tailored gene expression using user-defined thresholds may avoid data normalization issues [@bb0165]. However, using arbitrary thresholds may lead to subjective results that lose the fine-grained information for individual genes. This is because the specific threshold above which the level of gene expression indicates physiological activeness of corresponding reactions may vary across genes, conditions, or organisms. The following two methods incorporate continuous gene expression values without using thresholds.

E-Flux (as a combination of flux and expression) published in 2009 is a method that maps continuous gene expression levels into flux bound constraints according to gene--protein--reaction (GPR) associations [@bb0235; @bb0240]. It uses transcriptomic data to set upper and lower bounds on metabolic fluxes so that reactions associated with more highly expressed genes will be allowed to have higher absolute flux values ([Fig. 2](#f0010){ref-type="fig"}f). The rationale behind E-flux is that, given a limited translational efficiency and a limited accumulation of enzyme over the time, the level of mRNA can be used as an approximate upper bound on the maximum amount of metabolic enzymes, and hence as a bound on reaction rates. Using this method, the authors correctly predicted decreased mycolic acid synthesis by seven of the eight known fatty acid inhibitors in *M. tuberculosis*. In a follow-up study [@bb0240], they identified preferred carbon sources of *E. coli* that are not influenced by expression derived constraints.

An approach suggested by Lee et al. uses transcriptomic data in the objective function [@bb0245]. This method predicts intracellular metabolic fluxes by minimizing the deviation between the flux distribution and the transcriptomic data ([Fig. 2](#f0010){ref-type="fig"}g). The deviation was calculated by the sum of absolute differences between fluxes and corresponding gene expression data. The assumption behind this method is that enzymatic transcript concentrations and metabolic fluxes can be related to each other, albeit in a complex manner, since the existence of a transcript is necessary but not sufficient for the presence or activity of its corresponding enzyme [@bb0250]. They compared this method against FBA, GIMME, and iMAT, showing a better accuracy in predicting experimentally measured exometabolic flux for *S. cerevisiae* cultures under two growth conditions. FALCON (Flux Assignment with Least absolute deviation Convex Objectives and Normalization) is a recently published, related method with improvements in time efficiency [@bb0255].

4. Grouping criterion 3: requirement for a priori assumption of an appropriate objective function {#s0020}
=================================================================================================

The third feature that can distinguish the methods is whether a method requires the a priori assumption of an appropriate biological objective function.

Except for the method of Lee et al. and iMAT, the other methods described here need a priori knowledge of an appropriate objective function of the system such as biomass production rate. The biomass flux (i.e. the growth rate) is the most widely used objective function for FBA optimization problems since it is commonly assumed that, under given resources, efficient growth of a certain microorganism compared to its competitors is beneficial for its survival from an evolutionary perspective [@bb0260; @bb0265]. Indeed, the assumption of biomass flux maximization in FBA has successfully predicted metabolic behavior of various organisms in a number of studies [@bb0270; @bb0275]. Nevertheless, biomass flux may be unsuitable as an objective function for some organisms such as microorganisms with variable biomass composition, pathogens in dormancy or in latent phase, or cells of a multi-cellular organism [@bb0280]. Thus, in practical applications, we sometimes need methods like the method of Lee et al. and iMAT whose objective functions can be universally applied to a variety of organisms in cases where knowledge of the biological objective function is uncertain.

5. Grouping criterion 4: validation of predicted fluxes directly against measured intracellular fluxes {#s0025}
======================================================================================================

The last distinction among the methods is the utilization of measured intracellular fluxes for the purpose of validation. Basically, the output of the methods described here is predicted intracellular metabolic flux distribution. With the exception of the method of Åkesson et al., none of these methods, however, have tested their predictive accuracy against experimentally measured intracellular fluxes. Lee et al. did attempt to validate their predictions for the intracellular fluxes indirectly using exometabolomic data by measuring changes in the concentration of extracellular metabolites. Nevertheless, considering that detailed information on the underlying mechanisms of metabolic responses is not accessible from extracellular physiological data, it would be preferable to validate predictive accuracy using measured intracellular fluxes [@bb0285].

[Table 1](#t0005){ref-type="table"} summarizes the features of the presented methods with regard to the four grouping criteria described so far.

6. Summary and outlook {#s0030}
======================

Given its many advantages, the integration of transcriptomic data in a genome-scale model is a promising method for predicting system-level intracellular metabolic fluxes. From a practical perspective, we suggest that an ideal method satisfies all of the following criteria: a method that needs a single gene expression dataset as input; that utilizes continuous gene expression values without using arbitrary thresholds; that can be used even when an appropriate objective function is unknown; and whose predictive accuracy is validated against measured intracellular fluxes data.

Yet none of the surveyed methods satisfies all of the practical conditions. Lee\'s method seems to be the most practical method among them in that it achieves three of the four criteria for a practically ideal method. An important limitation of the currently available methods including Lee\'s method is that, except for the Åkesson\'s method, their predictive accuracy has not been validated directly against experimentally measured intracellular fluxes. Considering that the major purpose of developing these methods is to accurately predict context-specific intracellular metabolic flux distribution, it would be better if existing or new methods prove how accurately they predict intracellular metabolic distribution by comparing their results with in vivo intracellular flux data.

Importantly, the most practical method does not guarantee the best or the most accurate method. The choice of the most appropriate method would depend on various factors such as biological systems of interest, primary objective of study, and the availability of experimental data. For instance, if we study fast-growing microorganisms such as *E. coli* and *S. cerevisiae* of which the assumption of biomass flux maximization in FBA has successfully predicted metabolic behavior, using the methods such as E-Flux and Åkesson\'s method that need a priori knowledge of an appropriate objective function of the system would not be a problem. However, in order to study a broad range of systems including microorganisms with variable biomass composition, pathogens in dormancy or in latent phase, or cells of a multi-cellular organism, the methods such as Lee\'s method and iMAT whose objective functions can be universally applied to a variety of conditions are more desirable for such practical applications. In addition, if we focus on examining clear changes in metabolic behavior of a system, and want to avoid data normalization issues, using the methods that require binarized gene expression data would be appropriate. However, if we need to see more finely grained information, and if it is hard to define the specific threshold above which the level of gene expression indicates physiological activeness of corresponding reactions, using the methods which incorporate continuous gene expression values would be useful. Lastly, although PROM is sorted as an impractical method in [Table 1](#t0005){ref-type="table"} mainly due to its requirements for a large number of experimental datasets with regulatory information, PROM identified knock-out phenotypes for *E. coli* and *M. tuberculosis* with accuracies as high as 95% [@bb0190]. Still, as a recent research paper shows that the methods that use multiple gene expression datasets does not necessarily give more accurate flux predictions [@bb0165], the requirement for a large amount of input data to perform the analysis, which might make the job more onerous, could be considered as another limitation of some of the existing methods from a practical point of view.

In this paper, we introduced four different grouping criteria which enable to categorize methods for integration of transcriptomic data in genome-scale metabolic models. Based on these criteria, we suggested features of a practically ideal method. Then, we discussed about which group of the existing methods is more suitable to use for different cases from a practical perspective. Considering that none of the surveyed methods satisfies all of the practical conditions, efforts to develop a new method that overcomes the limitations of the existing methods should be continued.
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![Flux balance analysis (FBA). This figure illustrates how FBA works with an example of the simple network below consisting of two metabolites, A and B, and three metabolic reactions. (a) To use FBA, the network is converted into a stoichiometric matrix, *S*, where the rows in *S* correspond to the metabolites of the metabolic network, and the columns represent the reactions. Each matrix element *s~ij~*, indicates a stoichiometric coefficient, that is, the number of molecules of the *i*th metabolite participating in the *j*th reaction. *s~ij~* = 0 means that the *i*th metabolite is not involved, and a positive or a negative *s~ij~* indicates that the *i*th metabolite is a product or a reactant of the *j*th reaction, respectively. (b) Under the steady state assumption, the metabolic flux distribution can be represented mathematically by *S*·*v* = 0, where *v* is a column vector whose elements are the unknown reaction rates (fluxes) through each of the reactions of *S*.(c) Since the resulting system, *S*·*v* = 0, is usually underdetermined, physiologically meaningful flux solutions need to be narrowed down from all the possible flux distributions by imposing additional constraints on the system (e.g. 0 ≤ *v* ≤ 2 in the figure) and by optimizing certain objective functions (e.g. *Max v*~3~ in the figure).](gr1){#f0005}

![Representative methods currently available for integration of transcriptomic data in genome-scale metabolic models. (a)--(g) show how each method integrates gene expression data onto the models. (a) PROM binarizes the gene expression data according to a user-supplied threshold. Then, it calculates the probability of a metabolic target gene being expressed relative to the activity of its regulating transcription factor from a large dataset of gene expression data. The flux maxima of the metabolic reaction associated with the metabolic target gene is constrained by a factor of this probability. (b) MADE creates a sequence of binary expression states using several datasets for differential gene expression so as to find the model that most closely reproduces the observed expression changes. (c) Åkesson\'s method is one of the earliest methods to integrate genome-wide expression data into genome-scale metabolic models. In this method, the fluxes of reactions whose corresponding genes are not expressed are constrained as zero. (d) GIMME consists of a two-step procedure. First, the method finds a flux distribution that optimizes a given biological objective such as growth and/or ATP production using FBA. Then, the method minimizes the utilization of 'inactive' reactions whose corresponding mRNA transcript levels are below a given threshold. (e) iMAT discretized gene expression data into tri-valued expression states, representing either low, moderate or high expression in the condition studied according to a user-specified threshold. Then, the method finds an optimal metabolic flux distribution that is the most consistent with the discrete gene expression data by maximizing the number of flux-carrying reactions associated with highly expressed enzymes and minimizing the number of flux-carrying reactions that correspond to lowly-expressed enzymes. (f) E-Flux maps continuous gene expression levels into flux bound constraints according to gene--protein--reaction (GPR) associations. It uses transcriptomic data to set upper and lower bounds on metabolic fluxes so that reactions associated with more highly expressed genes will be allowed to have higher absolute flux values. (g) Dave Lee\'s method uses transcriptomic data in the objective function. This method predicts intracellular metabolic fluxes by minimizing the deviation between the flux distribution and the transcriptomic data. The deviation was calculated by the sum of absolute differences between fluxes and corresponding gene expression data.](gr2){#f0010}
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Summary of the features of previous methods according to four grouping criteria described in this paper. Desirable features from a practical perspective are shaded in green.
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